FDA cites 8 firms on illegal marketing of ibuprofen gels

08/20/2009 | Google

The FDA sent warning letters to eight companies that market topical ibuprofen products as a safer alternative to pain pills without submitting valid evidence to support that claim. Progressive Emu, one of the drugmakers, said it removed the claim from the label of its drug Emuprofen.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC